Loading clinical trials...
Loading clinical trials...
A Phase II Study of Chidamide or Placebo in Combination With Carboplatin and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer
Conditions
Interventions
Chidamide
Paclitaxel
+2 more
Locations
8
China
Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
Beijing Chest Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Hebei Provincial Tumor Hospital
Shijiazhuang, Hebei, China
Jiangsu Cancer Hospital
Nanjing, Jiangsu, China
The first Hospital of China Medical University
Shenyang, Liaoning, China
Shanghai Chest Hospital Affiliated to Shanghai Jiaotong University
Shanghai, Shanghai Municipality, China
Start Date
April 1, 2013
Primary Completion Date
May 1, 2015
Completion Date
December 1, 2015
Last Updated
February 1, 2016
NCT07336732
NCT05568212
NCT06574347
NCT02448992
NCT06281964
NCT05904379
Lead Sponsor
Chipscreen Biosciences, Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions